Headquartered in Canton, Massachusetts, Organogenesis Inc. is a global leader in regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’ versatile portfolio is designed to treat a variety of patients with repair and regenerative needs.
Location: United States, Massachusetts, Canton
Employees: 501-1000
Phone: +1 781-575-0775
Total raised: $250M
Founded date: 1985
Investors 1
Date | Name | Website |
- | Avista Cap... | avistacap.... |
Funding Rounds 3
Date | Series | Amount | Investors |
09.08.2021 | - | $200M | - |
22.05.2017 | - | $20M | Eastward C... |
14.04.2016 | - | $30M | - |
Mentions in press and media 13
Date | Title | Description | Source |
12.03.2024 | Global Skin Grafting Device Market Size to Surpass US$ 1,519... | Global Skin Grafting Device Market size is expected to reach US$ 1,519.0 Million by 2030, from US$ 9... | einpresswi... |
02.11.2022 | OmniAb Announces Completion of Spin-Off and Business Combina... | Leading Antibody Discovery Technologies Enable Development of Innovative Therapeutics Regular-way T... | avistacap.... |
09.08.2021 | Organogenesis Holdings Inc :. Announces New $200 Million Cre... | CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leadi... | marketscre... |
04.03.2019 | New Study Shows PuraPly® Antimicrobial Positively Impacts Co... | Canton, MA, March 4, 2019 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medic... | avistacap.... |
19.08.2018 | Avista Healthcare Public Acquisition Corp. To Combine With O... | Avista Healthcare Public Acquisition Corp. (NASDAQ :AHPA ), a publicly traded special purpose acquis... | citybizlis... |
23.05.2017 | Term Sheet — Tuesday, May 23 | FALSE START Good morning – today’s column didn’t come together in time. Back tomorrow! • Can China S... | fortune.co... |
22.05.2017 | Organogenesis Receives $20M Financing Facility from Eastward... | Organogenesis, Inc., a Canton, Mass.-based developer of advanced wound care innovation and technolog... | finsmes.co... |
22.05.2017 | Organogenesis Closes on a $20 Million Facility from Eastward... | Organogenesis Inc., a commercial leader in the field of regenerative medicine focusing on advanced w... | citybizlis... |
22.05.2017 | Organogenesis Closes on a $20 Million Facility from Eastward... | Organogenesis Inc., a commercial leader in the field of regenerative medicine focusing on advanced w... | archive.ci... |
14.04.2016 | Daily funding roundup - April 14, 2016 | Quartet raised $40M Series B; Imara secured $31M; Vyomo rebranded and received investment; Yup, form... | vator.tv/n... |
Show more